Relationship of the serum procalcitonin level with the severity of acute pancreatitis

Research Communications in Molecular Pathology and Pharmacology

Volumn 115-116, Issue , 2004, Pages 243-249

  Sato, Nobuhiro ^a   Endo, Shigeatsu ^a   Kasai, Takeshi ^a   Inoue, Yoshihiro ^a   Fujino, Yasuhisa ^a   Onodera, Makoto ^a   Imai, Satoko ^a   Takahashi, Gaku ^a   Miyata, Michiko ^a   Kitamura, Michihiko ^b   Wakabayashi, Go ^c  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Iwate Prefectural Isawa Hospital   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Multiple organ dysfunction syndrome; Pancreatitis; Procalcitonin; Ranson scoring system; Tumor necrosis factor

Indexed keywords

PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ACUTE PANCREATITIS; ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; ACUTE DISEASE; ADULT; BLOOD; COMPARATIVE STUDY; HOSPITALIZATION; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PANCREATITIS;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PANCREATITIS; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447257121     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. ACCP/SCCM: Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992): Chest 1992 101:1644-1655/Crit Care Med 20:864-874.
2. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. (1993): High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515-518.
3. Bertsch T., Richter A., Holfheinz H., Borm C., Hartet G., Aufenanger J. (1997) Procalcitonin. A new marker for acute phase reaction in acute pancreatitis. langenbecks Archiv fur Chirurgie 382: 367-372.
4. Brunkhorst F.M., Clark A.L., Forycki Z.F., Anker S.D. (1999). Pyrexia, procalcitonin, Immune activation and survival in cardiogenic shock. J. Int. Cardiol. 72: 3-10.
5. Carsin H., Assicot M., Ferger F., Roy O., Pennacino I., Le Bever H. (1997). Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF-α and endotoxin levels early after thermal injury. Burns 23:218-224.
6. De Werra I., Jaccard C., Corradin S.B., Chiolero R., Yersin B., Gallati H. (1997). Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentration: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607-613.
7. Endo S., Inada K., Inoue Y., Yamada Y., Fujino Y., Miura M., Baba E., Sato N., Wakabayashi G., Katsuya H., Sato S. (2000). Nuclear matrix protein increased in patients with pancreatitis. J. Medicine 31:320-326.
8. Gendrel D., Assicot M., Raymond J., Moulin F., Francoul C., Badoual J. (1996). Procalcitonin as a marker for the early diagnosis of neonatal infection. J. Pediatr. 128:570-573.
9. Gramm H-J., Dollinger P, Beier W. (1995). Procalcitonin - ein neuer Marker der Inflammatorischen Wirtsantwort Longitudinalstudien bei Patienten mit Sepsis und Peritonitis. Chir. Gastroenterol. 11: S51-S54.
10. Kuse E.R., Langefeld I., Jaeger K., Kulpmann W.R. (2000). procalcitonin-a new diagnostic tool in complications following liver transplantation. Intensive Care Med. 26:S187-S192.
11. Kylanpaa M.L., Takala A., Kemppainen E.A. (2001). Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit. Care Med. 29:63-69.
12. Mimoz O., Benoist J.F., Edouard A.R., Assicot M., Bohuon C., Samii K. (1998). Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 24:185-188.
13. Miura M., Endo S., Inada K., Inoue Y., Yamada Y., Fujino Y., Baba E., Wakabayashi G., Katsuya H., Sato N., Sato S. (2000). Tumor necrosis factor α and NOx levels in patients With pancreatitis. Crit. Care & Shock 3:189-194.
14. Miura M., Endo S, Kaku L., Inoue Y., Sato N., Wakabayashi G., Nakae H., Nakanishi L., Baba E., Katsuya H., Inada K., Sato S. (2001). Plasma type II PLA2 levels in patients with acute pancreatitis. Res. Commun. Molecul. Phathol. Pharmacol. 109:65-72.
15. Nakae H., Endo S., Inoue Y., Fujino Y., Onodera M., Sakamoto T., Inada K., Sato S. (2001). Chronological changes in the serum levels of endothelin-1 in patients with acute pancreatitis. Crit. Care & Shock 3:141-144
16. Nylen E.S., Snider R.H., Thompson K.A., Rohatgi P., Becker K.L. (1996). Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci 1996; 312: 12-18.
17. Oezcueruemez-Porsch M., Kunz D., Hardt P.D., Fadgyas T., Kress O., Schult H.U. (1998). Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Digestive Diseases & Sciences 43:1763-1769.
18. Ranson J.H.C. (1993). Acute pancreatitis: surgical management. In The Pancreatitis: Biology, Pathobiology and Disease. Second Edition, efited by go VLW et al. Raven Press, New York, 1993, pp637-648.
19. Rau B., Steinback G., Gansauger F., Mayer M., Grunert A., Neger H.G. (1997). The potential role of procalcitonin and interleucking 8 in the prediction of infected necrosis in acute pancreatitis. Gut 41:832-840.
20. Rau B., Steinbach G., Baumgart K., Gansauge F., Grunert A., Beger H.G. (2000). The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med 2000; 26:S159-S164.
21. Sachse C, Machens HG, Felmerer G. (1999). Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury. J Burn Care Rehabil 20:354-360.
22. Zajac J.D., Martin T.J., Hudson P. (1985). Biosynthesis of calcitonin by human lung cancer cells. Endocrinol 116:749-755.